These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27036110)

  • 21. Liver-Specific Overexpression of Prostasin Attenuates High-Fat Diet-Induced Metabolic Dysregulation in Mice.
    Sekine T; Takizawa S; Uchimura K; Miyazaki A; Tsuchiya K
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.
    Shigemasa K; Underwood LJ; Beard J; Tanimoto H; Ohama K; Parmley TH; O'Brien TJ
    J Soc Gynecol Investig; 2000; 7(6):358-62. PubMed ID: 11111072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
    Longuespée R; Boyon C; Castellier C; Jacquet A; Desmons A; Kerdraon O; Vinatier D; Fournier I; Day R; Salzet M
    Histochem Cell Biol; 2012 Jul; 138(1):141-54. PubMed ID: 22532226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
    Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
    Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin.
    Friis S; Madsen DH; Bugge TH
    J Biol Chem; 2016 Feb; 291(6):2577-82. PubMed ID: 26719335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse prostasin gene structure, promoter analysis, and restricted expression in lung and kidney.
    Verghese GM; Tong ZY; Bhagwandin V; Caughey GH
    Am J Respir Cell Mol Biol; 2004 Apr; 30(4):519-29. PubMed ID: 12959947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase.
    Chai AC; Robinson AL; Chai KX; Chen LM
    BMC Cancer; 2015 Dec; 15():1025. PubMed ID: 26715240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostasin (PRSS8) as a new pathological factor].
    Uchimura K; Kitamura K
    Nihon Rinsho; 2015 Mar; 73(3):523-33. PubMed ID: 25812384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case-control study.
    Pitynski K; Sporek A; Lipinska I; Banas T; Ludwin A; Bałajewicz-Nowak M
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):766-72. PubMed ID: 26701000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
    Chen PX; Li QY; Yang Z
    Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
    Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
    Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
    Szabo R; Lantsman T; Peters DE; Bugge TH
    Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong expression association between matriptase and its substrate prostasin in breast cancer.
    Bergum C; Zoratti G; Boerner J; List K
    J Cell Physiol; 2012 Apr; 227(4):1604-9. PubMed ID: 21678412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.
    Takahashi S; Suzuki S; Inaguma S; Ikeda Y; Cho YM; Hayashi N; Inoue T; Sugimura Y; Nishiyama N; Fujita T; Chao J; Ushijima T; Shirai T
    Prostate; 2003 Feb; 54(3):187-93. PubMed ID: 12518323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor PRSS8 targets Sphk1/S1P/Stat3/Akt signaling in colorectal cancer.
    Bao Y; Li K; Guo Y; Wang Q; Li Z; Yang Y; Chen Z; Wang J; Zhao W; Zhang H; Chen J; Dong H; Shen K; Diamond AM; Yang W
    Oncotarget; 2016 May; 7(18):26780-92. PubMed ID: 27050145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.